Publicaties - Interne-geneeskunde

01aug

Ixazomib, daratumumab and low-dose dexamethasone in intermediate-fit patients with newly diagnosed multiple myeloma: an open-label phase 2 trial.

»

01aug

High-throughput proteomics identifies THEMIS2 as independent biomarker of treatment-free survival in untreated CLL.

»

01aug

Predictors of the corrected count increment after platelet transfusion, a secondary analysis of the PACER randomized controlled trial.

»

01jul

Prognosis of IGLV3-21R110 chronic lymphocytic leukemia after chemotherapy-based treatment in a real-world analysis.

»

01jul

Determinants and mediating mechanisms of quality of life and disease-specific symptoms among thyroid cancer patients: the design of the WaTCh study.

»